Your browser doesn't support javascript.
Plasma P-selectin is an early marker of thromboembolism in COVID-19.
Fenyves, Bánk G; Mehta, Arnav; Kays, Kyle R; Beakes, Caroline; Margolin, Justin; Goldberg, Marcia B; Hacohen, Nir; Filbin, Michael R.
  • Fenyves BG; Department of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Mehta A; Department of Molecular Biology, Semmelweis University, Budapest, Hungary.
  • Kays KR; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Beakes C; Infectious Disease and Microbiome, Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA.
  • Margolin J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Goldberg MB; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Filbin MR; Department of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Am J Hematol ; 96(12): E468-E471, 2021 12 01.
Article in English | MEDLINE | ID: covidwho-1460140

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thromboembolism / P-Selectin / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Aged / Female / Humans / Male Language: English Journal: Am J Hematol Year: 2021 Document Type: Article Affiliation country: Ajh.26372

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Thromboembolism / P-Selectin / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Aged / Female / Humans / Male Language: English Journal: Am J Hematol Year: 2021 Document Type: Article Affiliation country: Ajh.26372